1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
European retrospective study of real-life haemophilia treatment
(
- Contribution to journal › Article
- 2016
-
Mark
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
2016) In Haemophilia(
- Contribution to journal › Article
- 2006
-
Mark
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
(
- Contribution to journal › Article
- 2004
-
Mark
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
(
- Contribution to journal › Article
- 2001
-
Mark
Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis
2001) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 16(2). p.9-313(
- Contribution to journal › Article
-
Mark
Ny in vitro-analys prövad: Blödningstid fortfarande bästa metod för test av den primära hemostasen
(
- Contribution to journal › Article
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
(
- Contribution to journal › Article
-
Mark
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
- 1996
-
Mark
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article